COMPANY PROFILE

InnoPharma

Explore full profile

Pfizer: One of the world's premier biopharmaceutical companies

Piscataway Township, United StatesFounded 2005Biotech & Life Sciences

Valuation $50–100M Last recorded · 2012

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About InnoPharma

Innopharma Inc. is a pioneering pharmaceutical company focused on developing advanced drug formulations and technologies to improve patient outcomes. Operating in the highly competitive pharmaceutical market, Innopharma serves a diverse range of clients including healthcare providers, hospitals, and research institutions. The company's business model revolves around the research, development, and commercialization of innovative pharmaceutical products. Revenue is primarily generated through the sale of proprietary drugs and licensing agreements with other pharmaceutical companies. Innopharma's commitment to innovation is evident in its continuous investment in biotechnology and its strategic partnerships with leading industry players. The company is dedicated to addressing unmet medical needs and enhancing the quality of life for patients worldwide.

MoreLess Source: Dealroom company data

At a glance

Status: Acquired
Founded: 2005
Headquarters: Piscataway Township, United States
Employees: 10
Open positions: None listed
Dealroom signal: 68.7/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2c
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
ACQUISITION✓Exit	Sep 2014	$0	—	Pfizer	↗
DEBTDebt	Nov 2013	$20M	—	Undisclosed	—

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

InnoPharma website traffic

Latest recorded traffic for InnoPharma is 110 monthly website visits. InnoPharma's team declined 23.1% over the past year.

Latest monthly visits110 1-year team growth-23.1%

Monthly website visitsDec 2023–Dec 2023

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
BEBentoDental plan platform that connects organizations, employers, patients, and dentists directly without the need for traditional dental insurance companies	Boston, United States	Operational	49	$13M	$32M
ANAntegenesGenetic tests for personalized cancer risk prevention	Tartu, Estonia	Operational
SYSydnexisBiotech & Life Sciences	Del Mar, United States	Operational
PLPlumeA health tech company for the transgender community	Denver, United States	Operational
CHCabinet HealthA sustainable healthcare company, starting with over-the-counter medicine	New York City, United States	Operational
C2C2CareDesigns therapeutic solutions based on virtual reality in order to immerse patient in an environment that creates a certain stress	Sanary-sur-Mer, France	Operational
GTGyroscope TherapeuticsDeveloping one-time gene therapies for retinal diseases	London, United Kingdom	Acquired
GAGalenicumProduction and distribution of pharmaceutical goods in various formats	Esplugues de Llobregat, Spain	Operational